N/A
N=45
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET)
Heart Failure
Bottom Line
View on ClinicalTrials.gov: NCT01602731 ↗Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Nov 2015
Primary outcome: Primary: Feasibility of AMDD to Improve Medication Adherence Via Completion Rate — 15 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Automated Medication Dispensing Device (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Feb 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of AMDD to Improve Medication Adherence Via Completion Rate |
15 | — |
| SECONDARY Efficacy of AMDD to Improve Medication Adherence |
65; 97 | — |
Summary
Trialing an automated medication dispensing device (AMDD) to improve medication adherence in patients with heart failure.
Eligibility Criteria
Inclusion Criteria
- Patients with established diagnosis of clinical heart failure
- English-speaking
- Able to provide informed consent
- Able to participate in cognitive function testing
- Age over 18
Exclusion Criteria
- Life expectancy < 6 months
- Documented dementia requiring a caregiver
- inability to set up the AMDD at the patient's home due to technical limitations
Data sourced from ClinicalTrials.gov (NCT01602731). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.